Market Place
Sourcing Support
Supriya Lifescience Posts 11% YoY Q3 FY26 Growth
14 Feb 2026 //
INDPHARMAPOST
Supriya Lifescience Targets Rs 1,600-Crore Revenue In 3 Years
22 Dec 2025 //
ECONOMICTIMES
Supriya Lifescience Aims For Rs 1,600Cr Revenue In 3 Years
17 Dec 2025 //
ECONOMICTIMES
Supriya Lifescience Eyes 33-35% Ebitda Margins In FY26
01 Sep 2025 //
NDTVPROFIT
ADHD,Contrast Media to Drive Growth by FY29: Supriya`s CFO
20 Aug 2025 //
FINANANCILXPRESS
Supriya Lifesciences Saloni & Shivani Wagh in Candere Hurun India
07 Jun 2025 //
EXPRESSPHARMA
Supriya Lifescience expands solar power capacity with 5 MWp facility
19 Mar 2025 //
EXPRESSPHARMA
Supriya Lifescience posts Q3 FY25 PAT up at Rs. 46.78 Cr
28 Jan 2025 //
INDPHARMAPOST
Union Budget 2025-26: roadmap for India’s pharmaceutical leadership
26 Jan 2025 //
EXPRESSPHARMA
Supriya Lifescience expands global footprint with Esketamine HCL
11 Dec 2024 //
PRESS RELEASE
Smallcap Pharma Stock with Strong Financials & Market Performance
29 Oct 2024 //
MARKETMOJO
Remarkable Entrepreneurial Journey of Dr. Satish Wagh in Pharma
25 Oct 2024 //
APNNEWS
Supriya Lifescience reports 21.7 per cent Y-o-Y revenue increase in Q1 FY24
13 Aug 2024 //
ECONOMICTIMES
Supriya Lifescience Ltd appoints Dr Saloni Wagh as MD
02 Aug 2024 //
ECONOMICTIMES
Supriya Lifescience promoter Wagh family’s next-gen to helm company
02 Aug 2024 //
THEHINDUBUSINESSLINE
Pharma industry experts eye budget boost for innovation and global ambitions
08 Jul 2024 //
EXPRESS PHARMA
Pharma sector demands substantial R&D incentives, tax relief & IP framework
04 Jul 2024 //
FINANCIAL EXPRESS
Pharma will be a major contributor to India’s economy: Dr Satish Wagh, Chairman
28 Mar 2024 //
FINANCIAL EXPRESS
Women`s integral role in India`s US$ 5 trillion ambition
11 Mar 2024 //
INDIANPHARMAPOST
Supriya Lifescience expects to double revenue to Rs 1,000 crore in next 3 years
09 Mar 2024 //
ECONOMICTIMES
In an interaction with Dr Saloni Wagh, Director of Supriya Lifescience Ltd
08 Mar 2024 //
DSIJ
Supriya Lifescience confident of meeting FY24 revenue guidance after strong Q3
12 Feb 2024 //
CNBC18
Supriya Lifesciences Q3 Results: Net profit triples to Rs 30 crore
08 Feb 2024 //
ECONOMICTIMES
Supriya Lifescience gets GMP certification from ANVISA Brazil
09 Jan 2024 //
EXPRESS PHARMA
Supriya CFO aims for Rs 1,000 crore revenue by FY27, advocates R&D policy
04 Jan 2024 //
ECONOMICTIMES
Supriya Lifescience jumps on bargain hunting
16 Feb 2023 //
BUSINESS-STANDARD
Supriya Lifescience Announces Rajeev Kumar Jain as CEO & Key Managerial Personnel
03 Oct 2022 //
PRESS RELEASE
Supriya Life gains on securing CEP for anti-histamine therapy
29 Sep 2022 //
BUSINESS STANDARD
Supriya Lifescience falls 6% on CEO`s resignation
28 Sep 2022 //
ECONOMIC TIMES
Supriya Lifescience Financial Year 2021-2022 Q3
21 Jan 2022 //
PRESS RELEASE
Supriya Lifescience Creating true values that bind global health
21 Jan 2022 //
PRESS RELEASE
Supriya Lifescience gets reality check; Hikal back in demand after 11 sessions
21 Jan 2022 //
ECONOMICTIMES
Un-Audited Financial Results For The Quarter Ended December 31, 2021
01 Jan 2022 //
PRESS RELEASE
Supriya Lifescience IPO subscribed 71.47 times on last day
20 Dec 2021 //
ECONOMICTIMES
Supriya Lifescience IPO fully booked in under 2 hours; should you subscribe
16 Dec 2021 //
FINANCIAL EXPRESS
Supriya Lifescience IPO to open on 16th December
13 Dec 2021 //
EXPRESSPHARMA
Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine
08 Jun 2021 //
GLOBENEWSWIRE
Supriya Lifescience files DRHP to raise Rs 1,200 crore via IPO
16 May 2021 //
ECONOMIC TIMES
